4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche

OBJECTIVES/GOALS: Breast cancer metastases are stochastic and difficult to detect. Therapy is often ineffective due to phenotypic changes of tumor cells at these sites. We engineered a synthetic metastatic niche to study the role of phenotypic transitions in the microenvironment on tumor cell phenot...

Full description

Bibliographic Details
Main Authors: Sophia Orbach, Michael D. Brooks, Grace G. Bushnell, Max S. Wicha, Jacqueline S. Jeruss, Lonnie D. Shea
Format: Article
Language:English
Published: Cambridge University Press 2020-06-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S205986612000062X/type/journal_article
_version_ 1811155121632968704
author Sophia Orbach
Michael D. Brooks
Grace G. Bushnell
Max S. Wicha
Jacqueline S. Jeruss
Lonnie D. Shea
author_facet Sophia Orbach
Michael D. Brooks
Grace G. Bushnell
Max S. Wicha
Jacqueline S. Jeruss
Lonnie D. Shea
author_sort Sophia Orbach
collection DOAJ
description OBJECTIVES/GOALS: Breast cancer metastases are stochastic and difficult to detect. Therapy is often ineffective due to phenotypic changes of tumor cells at these sites. We engineered a synthetic metastatic niche to study the role of phenotypic transitions in the microenvironment on tumor cell phenotype. METHODS/STUDY POPULATION: The engineered metastatic niche is composed of a porous polycaprolactone scaffold implanted subcutaneously in Balb/c mice. The mice received an orthotopic inoculation of 4T1 cells (murine triple negative breast cancer) in the fourth right mammary fat pad and the disease was allowed to progress for 7-21 days (pre-metastatic to overt metastatic disease). The scaffolds and lungs (native metastatic site) were explanted and analyzed by single cell RNA-seq via Drop-seq. Cell phenotypes were identified and tracked over time with the Seurat and Monocle3 pipelines. Assessment of the impact of these cell populations on tumor cell phenotype was conducted through Transwell co-cultures. RESULTS/ANTICIPATED RESULTS: Healthy scaffolds are primarily composed of macrophages, dendritic cells, and fibroblasts – consistent with a foreign body response. Despite differences in the lung and scaffold prior to tumor inoculation, both tissues were marked by >5-fold increase in neutrophils/MDSCs. Additionally, 79% of genes at the scaffold that significantly changed over time were also identified in the lung, indicating key similarities in niche maturation. However, many immune cells at the scaffold had distinct phenotypes, with pro-inflammatory/cytotoxic characteristics. These changes clearly impacted tumor cell phenotype, as cells from the scaffold increased tumor cell migration and apoptosis in vitro. DISCUSSION/SIGNIFICANCE OF IMPACT: Early phenotypic changes at the engineered metastatic niche can identify signs of metastasis prior to colonization of tumor cells. Furthermore, dynamics of immune and stromal cells change throughout niche maturation, influencing tumor cell phenotype and may suggest targeted therapies. CONFLICT OF INTEREST DESCRIPTION: Lonnie Shea, Jacqueline Jeruss, and Grace Bushnell are named inventors on patents or patent applications.
first_indexed 2024-04-10T04:27:43Z
format Article
id doaj.art-c6dfa113ff9e49869012604e79527314
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:27:43Z
publishDate 2020-06-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-c6dfa113ff9e49869012604e795273142023-03-10T08:51:36ZengCambridge University PressJournal of Clinical and Translational Science2059-86612020-06-0145610.1017/cts.2020.624026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic nicheSophia Orbach0Michael D. Brooks1Grace G. Bushnell2Max S. Wicha3Jacqueline S. Jeruss4Lonnie D. Shea5University of Michigan School of MedicineUniversity of MichiganUniversity of MichiganUniversity of MichiganUniversity of MichiganUniversity of MichiganOBJECTIVES/GOALS: Breast cancer metastases are stochastic and difficult to detect. Therapy is often ineffective due to phenotypic changes of tumor cells at these sites. We engineered a synthetic metastatic niche to study the role of phenotypic transitions in the microenvironment on tumor cell phenotype. METHODS/STUDY POPULATION: The engineered metastatic niche is composed of a porous polycaprolactone scaffold implanted subcutaneously in Balb/c mice. The mice received an orthotopic inoculation of 4T1 cells (murine triple negative breast cancer) in the fourth right mammary fat pad and the disease was allowed to progress for 7-21 days (pre-metastatic to overt metastatic disease). The scaffolds and lungs (native metastatic site) were explanted and analyzed by single cell RNA-seq via Drop-seq. Cell phenotypes were identified and tracked over time with the Seurat and Monocle3 pipelines. Assessment of the impact of these cell populations on tumor cell phenotype was conducted through Transwell co-cultures. RESULTS/ANTICIPATED RESULTS: Healthy scaffolds are primarily composed of macrophages, dendritic cells, and fibroblasts – consistent with a foreign body response. Despite differences in the lung and scaffold prior to tumor inoculation, both tissues were marked by >5-fold increase in neutrophils/MDSCs. Additionally, 79% of genes at the scaffold that significantly changed over time were also identified in the lung, indicating key similarities in niche maturation. However, many immune cells at the scaffold had distinct phenotypes, with pro-inflammatory/cytotoxic characteristics. These changes clearly impacted tumor cell phenotype, as cells from the scaffold increased tumor cell migration and apoptosis in vitro. DISCUSSION/SIGNIFICANCE OF IMPACT: Early phenotypic changes at the engineered metastatic niche can identify signs of metastasis prior to colonization of tumor cells. Furthermore, dynamics of immune and stromal cells change throughout niche maturation, influencing tumor cell phenotype and may suggest targeted therapies. CONFLICT OF INTEREST DESCRIPTION: Lonnie Shea, Jacqueline Jeruss, and Grace Bushnell are named inventors on patents or patent applications.https://www.cambridge.org/core/product/identifier/S205986612000062X/type/journal_article
spellingShingle Sophia Orbach
Michael D. Brooks
Grace G. Bushnell
Max S. Wicha
Jacqueline S. Jeruss
Lonnie D. Shea
4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
Journal of Clinical and Translational Science
title 4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
title_full 4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
title_fullStr 4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
title_full_unstemmed 4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
title_short 4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
title_sort 4026 dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
url https://www.cambridge.org/core/product/identifier/S205986612000062X/type/journal_article
work_keys_str_mv AT sophiaorbach 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche
AT michaeldbrooks 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche
AT gracegbushnell 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche
AT maxswicha 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche
AT jacquelinesjeruss 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche
AT lonniedshea 4026dissectingtheroleofmicroenvironmentheterogeneityonmetastatictumorcellphenotypeatanengineeredmetastaticniche